Delivery Order SPE2DR25D2206-SPE2DR26F9AS3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units with a ceiling value of $2,633.58. This firm fixed price contract, awarded on September 9, 2025, represents a non-set-aside competitive award with an ultimate completion date of September 10, 2025. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.59 to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units, with a completion date of September 8, 2025. This is a firm fixed price, non-set-aside delivery order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Ointment in 22-gram units, with a ceiling value of $2,900.42. This firm fixed price delivery order, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract utilizes no set-aside designation and will be performed...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, with a contract ceiling value of $5,614.00 and a firm fixed price. The award was competitively procured without set-aside designation and is scheduled for completion by August 22, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,837.43 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units. This is a firm fixed price delivery order with no set-aside designation, completed under open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $3,448.43 delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment (22 GM) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,362.14, is for the delivery of mupirocin 2% ointment, a topical antibiotic medication. The order has a firm fixed price and an ultimate completion date of August 16, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $1,857.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Mupirocin 2% Ointment 22GM. The contract has a completion date of September 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a wide range of medical commodities, including prescription drugs and...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.31 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream 15GM on September 8, 2025, with completion expected by September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.84 to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream in 15-gram units. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AS3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units on November 6, 2025, with a ceiling value of $1,393.99 and a firm fixed price structure. The delivery order represents a non-competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion value through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, and this order exemplifies the company's role in supplying essential medical commodities to support Department of Defense healthcare operations. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio under the DLA Troop Support Medical prime vendor contract, which enables the company to furnish a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to military healthcare customers worldwide. The contract completion date is set for November 7, 2025, reflecting the expedited nature of this particular delivery order for the topical antibiotic ointment. As a child contract under the larger IDC vehicle, this award demonstrates the company's continued capability to fulfill federal medical procurement requirements and supports the Defense Health Agency's pharmaceutical supply chain objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/6/25 |